Evidence map›Paper›PMID 35851701›Full record

ArticleCell proliferation2022

Fibroblast growth factor 10 protects against UVB-induced skin injury by activating the ERK/YAP signalling pathway.

Nan Wang, Yetong Dong, Xiejun Xu, Yingjie Shen, Zhiyuan Huang, Yin Yu, Zhili Liu, Wenjie Gong, Siyi Zhang, Yeyi Zheng and 4 more

Open access · goldAbstract read
In one paragraph

Article in Cell proliferation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. FGF family in health and disease.Molecular biomedicine · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. YAP/TAZ Signalling Controls Epidermal Keratinocyte Fate.International journal of molecular sciences · 2024
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Nan WangSchool of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, People's Republic of China.
Yetong DongSchool of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, People's Republic of China.
Xiejun XuSchool of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, People's Republic of China.
Yingjie ShenSchool of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, People's Republic of China.
Zhiyuan HuangSchool of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, People's Republic of China.
Yin YuSchool of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, People's Republic of China.
Zhili LiuSchool of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, People's Republic of China.
Wenjie GongSchool of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, People's Republic of China.
Siyi ZhangSchool of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, People's Republic of China.
Yeyi ZhengSchool of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, People's Republic of China.
Yonghuan SongDepartment of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China.
Zhongxin ZhuSchool of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, People's Republic of China.
Litai JinSchool of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, People's Republic of China.
Weitao CongSchool of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, People's Republic of China.ORCID https://orcid.org/0000-0002-1033-291X
Wenzhou Medical University · CNChonnam National University · KR

Funding

National Natural Science Foundation of China 82070507Natural Science Foundation of Zhejiang Province LY22H110002Natural Science Foundation of Zhejiang Province LZ21H020002
6 · The paper itself

Abstract

objectivesUltraviolet light B (UVB) irradiation can induce skin injury and result in keratinocytes proliferation inhibition. However, the molecular understanding of the repair during UVB-induced cell proliferation inhibition remains poorly understood. The purpose of this study was to explore the role and potential mechanism of FGF10 in promoting keratinocytes cell cycle and proliferation after UVB injury. MATERIALS AND

methodsExpression of FGF10 protein was analysed in skin treated with UVB radiation by immunohistochemistry. The proliferation potential was examined by Immunofluorescence, Western Blot and RT-PCR under UVB radiation, treated with FGF10 protein or overexpression of FGF10 using adeno-associated virus. CCK8 kit was used to further detect cell proliferation ability.

resultsWe found that FGF10 is highly expressed in skin treated with UVB. Overexpression of FGF10 has a protective effect against UVB-induced skin damage by balancing epidermal thickness and enhancing epidermal keratinocytes proliferation. Importantly, FGF10 is found to alleviate UVB-induced downregulation of YAP activity, then promoting keratinocytes proliferation. Disruption of YAP function, either with the small molecule YAP inhibitor Verteporfin (VP) or YAP small-interfering RNA (siRNA), largely abolishes the protective activity of FGF10 on epidermal keratinocytes proliferation. Meanwhile, disruption of ERK kinase (MEK) activity with U0126 or ERK siRNA hinder the positive influence of FGF10 on UVB-induced skin injury.

conclusionFGF10 promotes epidermal keratinocytes proliferation during UVB-induced skin injury in an ERK/YAP-dependent manner.

Indexed as

KeratinocytesUltraviolet RaysFibroblast Growth Factor 10RNA, Small InterferingSignal TransductionFibroblast Growth Factor 10RNA, Small Interfering

Identifiers

PMID35851701
PMCPMC9628220
OpenAlexW4286229677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.